Eiropas Savienība - angļu - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv)

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - dexamethasone, quantity: 700 microgram - implant - excipient ingredients: polyglactin - ozurdex is indicated for the treatment of:,- diabetic macular oedema (dme),- macular oedema due to branch retinal vein occlusion (brvo) or central retinal vein occlusion (crvo).,- non-infectious uveitis affecting the posterior segment of the eye. ozurdex is indicated for the treatment of diabetic macular oedema (dme).

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - ketorolac trometamol - eye drops - 5mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - ketorolac trometamol - eye drops - 5mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - ketorolac trometamol - eye drops - 5mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - ketorolac trometamol - eye drops - 5mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - ketorolac trometamol - eye drops - 5mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - ketorolac trometamol - eye drops - 5mg/1ml

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - ketorolac trometamol - eye drops - 5mg/1ml

Eiropas Savienība - angļu - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - dexamethasone - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex is indicated for the treatment of adult patients with macular oedema following either branch retinal-vein occlusion (brvo) or central retinal-vein occlusion (crvo).ozurdex is indicated for the treatment of adult patients with inflammation of the posterior segment of the eye presenting as noninfectious uveitis.ozurdex is indicated for the treatment of adult patients with visual impairment due to diabetic macular oedema (dme) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy.